OPRM1 and depressive disorder: Early clinical studies performed from the late 1970 s first explored the potential antidepressant effects of IV infusions of synthetic β-endorphin (a MOR ligand) in the treatment of depression (Kline et al., 1977, Angst et al., 1979, Gerner et al., 1980, Pickar et al., 1981).